AIDS drug trials enter new age
Palca, J.
Science 246(4926): 19-21
1989
ISSN/ISBN: 0036-8075 PMID: 2506644 DOI: 10.1126/science.2506644Document Number: 381914
Document emailed within 0-6 h
Related Documents
2005: New microbicides enter trials in United States Aids Alert 20(1): 10-11Carlisle, D. 1993: AIDS services to enter mainstream Nursing Times 89(48): 9
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Feigal, E.G.; Phillips, P.H.; Cheson, B.D. 1997: Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies Oncology 11(3): 337-338; 341
Zani, B.; Pienaar, E.D.; Oliver, J.; Siegfried, N. 2011: Randomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register Plos one 6(12): E28759
Hochster, H.; Dieterich, D.; Bozzette, S.; Reichman, R.C.; Connor, J.D.; Liebes, L.; Sonke, R.L.; Spector, S.A.; Valentine, F.; Pettinelli, C. 1990: Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study Annals of Internal Medicine 113(2): 111-117
Benson, C.A.; Williams, P.L.; Cohn, D.L.; Becker, S.; Hojczyk, P.; Nevin, T.; Korvick, J.A.; Heifets, L.; Child, C.C.; Lederman, M.M.; Reichman, R.C.; Powderly, W.G.; Notario, G.F.; Wynne, B.A.; Hafner, R. 2000: Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team Journal of Infectious Diseases 181(4): 1289-1297
Etheridge, R.M.; Craddock, S.G.; Wechsberg, W.M. 1995: Counseling and services for HIV infection, AIDS and AIDS-risk behaviors in drug abuse treatment Findings from the NIDA drug abuse treatment outcome study PHILADELPHIA SCIENCES GROUP HIV infection in women: Setting a new agenda : P99
Gleiter, C.H.; Bieck, P.R. 1991: Clinical drug trials. 1: the 4 phases of clinical trials Fortschritte der Medizin 109(5): 136-137
Shilling, R.A.; Subramanian, N.; Dowlati, A.; Gordon, S.; Ramnes, C.; Sedransk, N.; Lederman, M.; Remick, S.C. 1999: A composite clinical stage for AIDS-related Kaposis sarcoma A refinement of the AIDS clinical trials group clinical staging classification JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A23
Jaillon, P. 1985: Drug trials in man Revue de l'Infirmiere 35(11): 23-27
Van Rompay, K.K.; Marthas, M.L. 1997: Antiretroviral drug trials Science 276(5318): 1482-1484
Gerber, P.; Eadie, M. 1988: Ethics and drug trials Medical Journal of Australia 149(5): 229-230
Schulte-Wissermann, H. 2013: Clinical drug trials Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 32(6): 210
Randall, P.S. 1990: Anti-HIV drug available in trials Postgraduate Medicine 88(7): 23
Skene, L. 1989: Ethics and drug trials Medical Journal of Australia 150(1): 55